Company · CIK 0001607678 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Viking Therapeutics, Inc. · VKTX
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 1, 2026 AForm 4 → | Aug 7, 4:34 pm EDT | Dorothy Elizabeth Kelly-GemmellDirector | 6,333 | — | — | 6,333 | — | late |
| Jul 29, 2026 SForm 4 → | Jul 29, 8:07 pm EDT | Brian LianPresident & CEO, Director | 148,517 | $33.32 | $4,947,888 | 2,572,441 | −5.46% | |
| Jul 29, 2026 SForm 4 → | Jul 29, 8:06 pm EDT | Greg ZanteChief Financial Officer | 21,217 | $33.47 | $710,141 | 212,204 | −9.09% | |
| Jul 29, 2026 SForm 4 → | Jul 29, 8:06 pm EDT | Marianna ManciniChief Operating Officer | 18,217 | $33.47 | $609,636 | 422,760 | −4.13% | |
| Jul 28, 2026 AForm 4 → | Jul 29, 8:07 pm EDT | Brian LianPresident & CEO, Director | 221,667 | — | — | 2,720,958 | — | |
| Jul 28, 2026 AForm 4 → | Jul 29, 8:06 pm EDT | Greg ZanteChief Financial Officer | 31,667 | — | — | 233,421 | — | |
| Jul 28, 2026 AForm 4 → | Jul 29, 8:06 pm EDT | Marianna ManciniChief Operating Officer | 31,667 | — | — | 440,977 | — |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 1, 2026 AForm 4 → | Aug 7, 4:34 pm EDT | Dorothy Elizabeth Kelly-GemmellDirector | 40,800 | — | — | 40,800 | — | late |
| Jun 1, 2026 AForm 4 → | Jun 3, 7:44 pm EDT | Hubert C ChenChief Medical Officer | 190,000 | — | — | 190,000 | — |